This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Church & Dwight's (CHD) Buyout of Hero to Bolster Portfolio
by Zacks Equity Research
Church & Dwight (CHD) inks a deal to buy the Hero Mighty Patch brand (or Hero) and other acne treatment products. The deal is anticipated to close in the fourth quarter of 2022.
B&G Foods (BGS) Looks Troubled: High Input Cost a Key Concern
by Zacks Equity Research
B&G Foods (BGS) expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging, labor and transportation.
Kimberly-Clark's (KMB) Cost-Cutting Efforts Aid Amid High Costs
by Zacks Equity Research
Kimberly-Clark (KMB) is focused on undertaking relevant cost-cutting initiatives and pricing actions to counter inflation. Focus on three key strategic growth pillars is noteworthy.
Hormel Foods (HRL) Q3 Earnings Lag Estimates, Revenues Up Y/Y
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter top and bottom lines increase year over year. While management raises its sales view for fiscal 2022, it lowers its earnings per share guidance.
Tecnoglass and Monster Beverage have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tecnoglass and Monster Beverage are part of Zacks Bull and Bear of the Day article.
Pilgrim's Pride (PPC) Up More than 20% in 6 Months: Here's Why
by Zacks Equity Research
Pilgrim's Pride's (PPC) focus on key customers is a pathway for refining its portfolio and creating competitive advantages. Also, its efforts to expand in new regions bode well.
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, Campbell Soup, Celsius Holdings, Corteva and Hershey's
by Zacks Equity Research
Archer-Daniels-Midland, Campbell Soup, Celsius Holdings, Corteva and Hershey's are included in this Analyst Blog.
Do Options Traders Know Something About Celsius Holdings (CELH) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Celsius Holdings (CELH) stock based on the movements in the options market lately.
Top 5 High-Flying Consumer Staples Stocks With More Upside
by Nalak Das
We have narrowed our search to five consumer staples stocks that have popped year to date with more potential for the rest of 2022. These are: HSY, CELH, CPB, ADM and CTVA.
Here's Why Momentum in Celsius Holdings Inc. (CELH) Should Keep going
by Zacks Equity Research
Celsius Holdings Inc. (CELH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Is Celsius (CELH) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Celsius Holdings Inc. (CELH) and Chefs' Warehouse (CHEF) have performed compared to their sector so far this year.
Zacks.com featured highlights include Sensus Healthcare, Super Micro Computer, Universal Logistics Holdings, Arcosa and Celsius Holdings
by Zacks Equity Research
Sensus Healthcare, Super Micro Computer, Universal Logistics Holdings, Arcosa and Celsius Holdings are part of Zacks screen of the week article.
Celsius Holdings Inc. (CELH) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Celsius Holdings Inc. (CELH) delivered earnings and revenue surprises of 50% and 2.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks With Recent Price Strength to Enrich Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SRTS, SMCI, ULH, ACA and CELH.
Wolverine (WWW) Readies for Q2 Earnings: What to Expect
by Zacks Equity Research
Wolverine's (WWW) second-quarter 2022 earnings results might show higher costs, including SG&A expenses. However, strength in brands might aid the top line.
The Zacks Analyst Blog Highlights Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade
by Zacks Equity Research
Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade are part of Zacks top Analyst Blog.
TreeHouse Foods (THS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TreeHouse (THS) delivered earnings and revenue surprises of 76.47% and 8.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inter Parfums (IPAR) Readies for Q2 Earnings: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2022 results are likely to reflect solid sales due to a rise in Europe-based and U.S.-based product sales. Cost inflation and supply-chain woes are likely to have been concerns.
Sysco (SYY) Readies for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sysco's (SYY) fourth-quarter fiscal 2022 results are likely to reflect gains from the Recipe for Growth program, market share gains and efforts to counter cost inflation.
TreeHouse Foods (THS) Lined Up for Q2 Earnings: Things to Note
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter 2022 earnings results might show adverse impacts of commodity cost inflation, supply-chain disruptions and freight cost inflation.
Cogent (CCOI) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cogent Communications (CCOI) beats second-quarter earnings estimates due to the positive impact of foreign exchange rates
Cambium (CMBM) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cambium (CMBM) beats second-quarter earnings estimates despite soft revenues due to sluggishness from service providers.
Universal Display (OLED) Misses on Q2 Earnings and Revenues
by Zacks Equity Research
Universal Display (OLED) misses second-quarter earnings and revenue estimates due to headwinds weighing on consumer spending.
5 Stocks to Buy Ahead of Earnings Results Next Week
by Nalak Das
Five companies are slated to beat earnings estimates next week. These are: TTWO, IONS, CELH, LMND and GO.